Compositions and methods for prevention and treatment of metabolic steatosis and steatohepatitis
AssigneeInternational Nutrition Research Company
InventorClaude Vincent
Life of this patent
Estimating the term…
Abstract
The invention relates to an orally administered drug or medical nutrition composition for use in the prevention or treatment of metabolic steatosis and steatohepatitis of abdominally obese people with metabolic syndrome. The composition comprises at least: proteins and/or free amino adds, fibers selected at least from acacia gum fibers and/or fructooligosaccharide fibers, vitamins D, B6, B9, B12 and E, omega 3 in the form of ALA, glutathione, SOD, catalase, choline.
Claims23
An orally administered drug or medical nutrition composition for prevention and treatment of metabolic steatosis and steatohepatitis of abdominally obese people with metabolic syndrome, comprising at least:
- at least one of proteins and free amino acids,
- fibers selected at least from acacia gum fibers and fructooligosaccharide fibers,
- vitamins D, B6, B9, B12 and E,
- omega 3 in the form of ALA (ALPHA LINOLENIC ACID),
- glutathione,
- SOD (SUPEROXIDE DISMUTASE),
- catalase,
- choline,
- the entirety of the amino acids present in the composition, stemming from the proteins and free amino acids, representing 40 to 90 g per 100 g of composition (excluding any excipients), and the fibers representing between 3 and 8 g per 100 g of composition (excluding any excipients).
Dependencies are inferred from the claim text.